ONZETRA XSAIL: payments to doctors
Payments that named ONZETRA XSAIL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $184K
- Providers
- 3,508
- Transactions
- 8,455
- Average per transaction
- $22
The per-transaction average — $22 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,508 providers the average total is $53, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Currax Pharmaceuticals LLC | $184,488 | 100.0% |